Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Buy

BEAM
Beam Therapeutics

Last Price:

33.16

Seasonality Move:

-10%

7 Day Trial

ALL ACCESS PASS

$ 7

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.

Beam Therapeutics Price Quote

$33.16

+1.02 (+3.17%)

(Updated: July 26, 2024 at 6:55 PM ET)

Beam Therapeutics Key Stats

Buy

Beam Therapeutics (BEAM) is a Buy

Day range:

$29.88 - $33.43

52-week range:

$16.95 - $49.50

Dividend yield:

P/E ratio:

0.00

P/S ratio:

7.08

P/B ratio:

2.9%

Volume:

2.3M

Avg. volume:

1.6M

1-year change:

-0.99%

Market cap:

$2.6B

Revenue:

$377.7M

EPS:

$-1.78

How Much Does Beam Therapeutics Make?

How Much Are Beam Therapeutics's Sales Annually?
BEAM Revenues are $377.7M
How Much Profit Does Beam Therapeutics's Make A Year?
BEAM net income is -$132.5M

Is Beam Therapeutics Growing As A Company?

What Is Beam Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.69%
What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

Did Beam Therapeutics Stock Go Up Last Month?
Beam Therapeutics share price went up by 32.54% last month
Did BEAM's Share Price Rise Over The Last Year?
BEAM share price fell by -0.99% over the past 1 year

What Is Beam Therapeutics 52-Week High & Low?

What Is Beam Therapeutics’s 52-Week High Share Price?
Beam Therapeutics has traded as high as $49.50 over the past 52 weeks
What Is Beam Therapeutics’s 52-Week Low Share Price?
Beam Therapeutics has traded as low as $16.95 over the past 52 weeks

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

How Much Debt Does Beam Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Beam Therapeutics Have?
Cash and short term investments quarterly total is $1.1B
What Is Beam Therapeutics’s Book Value Per Share?
Book value per share is 11.10

Is Beam Therapeutics Cash Flow Positive?

What Is BEAM Cash Flow From Operations?
Cash flow from operations (TTM) is -$139.1M
What Is Beam Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $180.9M
What Is Beam Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7.1M

Beam Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
BEAM return on invested capital is -15.86%
What Is Beam Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -9.91%
What Is BEAM Return On Equity?
ROE is a measure of profitability and is -15.86%

Beam Therapeutics Earnings Date & Stock Price

What Is Beam Therapeutics's Stock Price Today?
A single share of BEAM can be purchased today for 32.14
What Is Beam Therapeutics’s Stock Symbol?
Beam Therapeutics trades on the nasdaq under the ticker symbol: BEAM
When Is Beam Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Beam Therapeutics is scheduled on August 8, 2024
When Is BEAM's next ex-dividend date?
Beam Therapeutics's next ex-dividend date is May 7, 2020
How To Buy Beam Therapeutics Stock?
You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Beam Therapeutics Competitors

Who Are Beam Therapeutics's Competitors?
Below is a list of companies who compete with Beam Therapeutics or are related in some way:
- Arcellx Inc (ACLX)
- Day One Biopharmaceuticals Inc (DAWN)
- Iovance Biotherapeutics Inc (IOVA)
- Intellia Therapeutics Inc (NTLA)
- Revolution Medicines Inc (RVMD)

Beam Therapeutics Dividend Yield